Cambridge, United Kingdom

Miles Stuart Congreve

USPTO Granted Patents = 93 

 

 

Average Co-Inventor Count = 5.4

ph-index = 14

Forward Citations = 686(Granted Patents)


Inventors with similar research interests:


Location History:

  • Royston, GB (2013 - 2014)
  • Melbourn, GB (2014)
  • Hertfordshire, GB (2014 - 2016)
  • Welwyn Garden City, GB (2017 - 2019)
  • Welwyn Garden, GB (2017 - 2019)
  • Cambridge, GB (2006 - 2024)
  • Cambridgeshire, GB (2024)

Company Filing History:


Years Active: 2006-2025

Loading Chart...
Loading Chart...
Loading Chart...
93 patents (USPTO):Explore Patents

Title: Innovation and Contributions of Miles Stuart Congreve

Introduction

Miles Stuart Congreve is a distinguished inventor based in Cambridge, GB, known for his remarkable contributions to the field of pharmacology and medicinal chemistry. With an impressive portfolio of 86 patents, Congreve has been at the forefront of developing novel compounds aimed at addressing various medical disorders.

Latest Patents

Among his latest patents, Congreve has introduced innovative CGRP antagonist compounds. These disclosures relate to novel compounds of Formula (1a) and their use in treating, preventing, ameliorating, controlling, or reducing the risk of disorders associated with CGRP receptors. Additionally, he has worked on quinolinone and benzoxazine derivatives as muscarinic M and/or M receptors agonists. This invention focuses on compounds with activity as muscarinic receptor agonists, useful in treating diseases mediated by these receptors. Furthermore, he provides pharmaceutical compositions containing these compounds alongside their therapeutic uses.

Career Highlights

Congreve's career has been marked by significant accomplishments in pharmaceutical research and development. He has held positions in reputable companies such as Heptares Therapeutics Limited and Astex Therapeutics Limited, where he played a pivotal role in advancing drug discovery and development processes.

Collaborations

Working alongside notable colleagues, including Benjamin Gerald Tehan and Giles Albert Brown, Congreve has fostered a collaborative environment that has led to numerous breakthroughs in medicinal chemistry. These partnerships have been instrumental in developing innovative solutions for complex health challenges.

Conclusion

Miles Stuart Congreve's innovative spirit and dedication to research have significantly impacted the pharmaceutical industry. His extensive patent portfolio reflects his commitment to creating effective treatments that improve patient outcomes. As he continues to explore new frontiers in drug development, his contributions remain crucial in addressing unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…